Immuno-Oncology Drugs Market Boosted by Biomarker-Driven Treatment...

agregó una foto Literature

2026-08-04 15:16:53 -

Immuno-Oncology Drugs Market Boosted by Biomarker-Driven Treatment Adoption

The global Immuno-oncology Drugs Market is set for sustained growth as healthcare systems increasingly favor targeted therapies that improve survival outcomes and reduce reliance on traditional chemotherapy. Market expansion is being driven by rising cancer prevalence, continued clinical success of checkpoint inhibitors and cell-based therapies, broader biomarker-based patient...

0 Commentarios 0 Acciones 52 Views 0 Vista previa